polatuzumab vedotin

An anti-CD79b antibody-drug conjugate (ADC)

An anti-CD79b antibody-drug conjugate, polatuzumab vedotin is designed to bind to the CD79b portion of the B-cell receptor complex1

CD=cluster of differentiation.